Edition:
United States

Sunesis Pharmaceuticals Inc (SNSS.OQ)

SNSS.OQ on NASDAQ Stock Exchange Capital Market

1.77USD
4:00pm EDT
Change (% chg)

$-0.07 (-3.80%)
Prev Close
$1.84
Open
$1.86
Day's High
$1.87
Day's Low
$1.71
Volume
27,267
Avg. Vol
32,745
52-wk High
$7.68
52-wk Low
$1.71

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

James Young

2009 Non-Executive Independent Chairman of the Board

Dayton Misfeldt

44 2018 Interim Chief Executive Officer, Director

William Quinn

2017 Chief Financial Officer, Senior Vice President - Finance and Corporate Development

Adam Craig

51 2012 Executive Vice President - Development, Chief Medical Officer

Stephen Ketchum

50 2012 Director